XML 50 R38.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Note 15 - Share-based Payments (Tables)

6 Months Ended

Jun. 30, 2024

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

		Three Months Ended June 30, 2024								Three Months Ended June 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			1,062,214			$	54.30				1,021,600			$	62.70
Granted			174,450				20.49				127,055				26.68
Exercised			-				-				-				-
Forfeited			(22,928	)			36.27				(9,439	)			62.26
Expired			(26,775	)			63.69				(7,334	)			63.84
Outstanding, end of period			1,186,961				49.43				1,131,882				55.84
Options exercisable, end of period			721,998			$	59.78				662,210			$	62.16

		Six Months Ended June 30, 2024								Six Months Ended June 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			1,132,632			$	54.61				1,036,748			$	59.97
Granted			176,950				20.20				137,055				26.36
Exercised			-				-				-				-
Forfeited			(72,972	)			21.87				(27,862	)			59.82
Expired			(49,649	)			59.95				(14,059	)			65.54
Outstanding, end of period			1,186,961				49.43				1,131,882				55.84
Options exercisable, end of period			721,998			$	59.78				662,210			$	62.16

		Three Months Ended June 30, 2024								Three Months Ended June 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			16,485,256			$	1.29				16,469,595			$	1.27
Granted			389,500				1.74				94,750				1.27
Exercised			-				-				-				-
Forfeited			(81,682	)			1.34				(84,063	)			1.27
Expired			(13,228	)			1.27				(16,317	)			1.27
Outstanding, end of period			16,779,846				1.30				16,463,965				1.27
Options exercisable, end of period			9,602,704			$	1.27				5,685,566			$	1.27

		Six Months Ended June 30, 2024								Six Months Ended June 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			16,333,233			$	1.27				15,975,528			$	1.27
Granted			919,500				1.74				675,500				1.27
Exercised			-				-				-				-
Forfeited			(301,954	)			1.33				(170,746	)			1.27
Expired			(170,933	)			1.27				(16,317	)			1.27
Outstanding, end of period			16,779,846				1.30				16,463,965				1.27
Options exercisable, end of period			9,602,704			$	1.27				5,685,566			$	1.27

		Three Months Ended June 30, 2024								Three Months Ended June 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			7,213,750			$	6.00				7,279,527			$	6.00
Granted			105,000				6.00				279,000				6.00
Exercised			-				-				-				-
Forfeited			(284,730	)			6.00				(115,338	)			6.00
Expired			(64,764	)			6.00				(14,527	)			6.00
Outstanding, end of period			6,969,256				6.00				7,428,662				6.00
Options exercisable, end of period			3,803,716			$	6.00				2,301,540			$	6.00

		Six Months Ended June 30, 2024								Six Months Ended June 30, 2023
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			7,504,269			$	6.00				-			$	-
Granted			123,000				6.00				7,594,000				6.00
Exercised			-				-				-				-
Forfeited			(447,980	)			6.00				(150,811	)			6.00
Expired			(210,033	)			6.00				(14,527	)			6.00
Outstanding, end of period			6,969,256				6.00				7,428,662				6.00
Options exercisable, end of period			3,803,716			$	6.00				2,301,540			$	6.00

Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$16.47 - $19.78			57,500			$	19.63				5.6			$	11				-			$	-				-			$	-
$21.07 - $28.37			276,222				23.31				6.5				-				29,155				26.78				6.0				-
$30.70 - $30.74			20,000				30.71				5.4				-				5,000				30.71				5.4				-
$40.04 - $48.00			189,527				42.29				4.9				-				103,802				42.58				4.9				-
$51.82 - $59.98			172,283				55.73				0.6				-				172,283				55.73				0.6				-
$60.01 - $68.41			254,156				62.08				2.2				-				252,335				62.09				2.2				-
$70.13 - $79.51			200,773				78.44				3.5				-				149,298				78.47				3.6				-
$80.61 - $82.07			16,500				81.27				4.3				-				10,125				81.42				4.3				-
			1,186,961			$	49.43				3.9			$	11				721,998			$	59.78				2.7			$	-

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $1.74			16,779,846			$	1.30				5.3			$	8,044				9,602,704			$	1.27				5.4			$	4,890
			16,779,846			$	1.30				5.3			$	8,044				9,602,704			$	1.27				5.4			$	4,890

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $6.00			6,969,256			$	6.00				5.8			$	-				3,803,716			$	6.00				5.8			$	-
			6,969,256			$	6.00				5.8			$	-				3,803,716			$	6.00				5.8			$	-

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

		Three Months Ended June 30,								Six Months Ended June 30,
		2024				2023				2024				2023
Company options		$	1,250			$	1,675			$	2,674			$	3,179
Wavelo options			490				510				959				1,056
Ting options			44				49				112				245
Capitalized stock based compensation			(82	)			(182	)			(170	)			(182	)
Total stock based compensation expense		$	1,702			$	2,052			$	3,575			$	4,298

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration